Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/ALA stock hub

ASX/ALA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/ALAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
91.9M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/ALA
In the news

Latest news · ASX/ALA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-52
P25 -118.7P50 -49.4P75 -1.2
ROIC-34.8
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/ALA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
AUD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Australia
Country code
AU
Employees
27
Enterprise value
AUD 72.5M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Biotechnology
Isin
AU0000182784
Last refreshed
2026-05-10
Market cap
AUD 91.9M
Price
AUD 0.08
Price currency
AUD
Rev Per Employee
118,878.44x
Sector
Healthcare
Sic
3841
Symbol
asx/ALA
Website
https://www.arovella.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-8.63%
EV Earnings
-9.15x
EV/FCF
-10.47x
EV/Sales
22.59x
FCF yield
-7.54%
P/B ratio
4.86x
P/S ratio
28.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-264.4%
EBITDA Margin
-260.73%
Gross margin
100%
Gross Profit
AUD 3.2M
Gross Profit Growth
-6.7%
Gross Profit Growth Q
-6.7%
Gross Profit Growth3 Y
18.03%
Gross Profit Growth5 Y
20.73%
Net Income
AUD -7.9M
Net Income Growth Years
2%
Pretax Margin
-246.95%
Profit Margin
-246.95%
Profit Per Employee
AUD -293,566
ROA
-32.25
Roa5y
-47.42
ROCE
-44.77
ROE
-52.05
Roe5y
-104.8
ROIC
-34.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr10y
-16.83%
Cagr15y
-12.2%
Cagr1y
-10.6%
Cagr20y
-16.09%
Cagr3y
0.89%
Cagr5y
14.87%
EPS Growth Years
3
Revenue Growth
-6.9x
Revenue Growth Q
-6.7x
Revenue Growth Years
1x
Revenue Growth3 Y
18.03x
Revenue Growth5 Y
17.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
AUD 0.2
Assets
AUD 20.2M
Cash
AUD 19.4M
Current Assets
AUD 19.8M
Current Liabilities
AUD 1.3M
Equity
AUD 18.9M
Liabilities
AUD 1.3M
Long Term Assets
AUD 408,733
Long Term Liabilities
AUD 37,458
Net Cash
AUD 19.4M
Net Cash By Market Cap
AUD 21.08
Net Cash Growth
64.81%
Net Debt Equity
AUD -1.02
Tangible Book Value
AUD 18.9M
Tangible Book Value Per Share
AUD 0.02
WACC
4.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
15.36
Net Working Capital
AUD -820,235
Quick ratio
15.09
Working Capital
AUD 18.5M
Working Capital Turnover
AUD 0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-14.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-84.15%
1Y total return
-10.59%
200-day SMA
0.09
3Y total return
2.7%
50-day SMA
0.08
50-day SMA vs 200-day SMA
50under200
5Y total return
100%
All Time High
22
All Time High Change
-99.65%
All Time High Date
2003-04-23
All Time Low
0.02
All Time Low Change
280%
All Time Low Date
2022-06-15
ATR
0
Beta
0.09
Beta1y
1.14
Beta2y
0.95
Ch YTD
-18.28
High
0.08
High52
0.13
High52 Date
2025-10-02
High52ch
-39.2%
Low
0.08
Low52
0.07
Low52 Date
2026-03-23
Low52ch
16.92%
Ma50ch
0.4%
Price vs 200-day SMA
-11.63%
RSI
49.33
RSI Monthly
43.56
RSI Weekly
43.98
Sharpe ratio
0.17x
Sortino ratio
0.39
Total Return
-14.71%
Tr YTD
-18.28
Tr15y
-85.79%
Tr1m
8.57%
Tr1w
-2.56%
Tr3m
-15.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -8.5M
Operating margin
-264.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
914,543,220%
Shares Insiders
14.4%
Shares Institutions
15.83%
Shares Out
1,208,783,672
Shares Qo Q
4.91%
Shares Yo Y
14.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
AUD -7.8M
Average Volume
1,425,190.5x
Bv Per Share
0.02
CAPEX
AUD -101,956
Ch10y
-88.31
Ch15y
-89.52
Ch1m
8.57
Ch1w
-2.56
Ch1y
-10.59
Ch20y
-98.04
Ch3m
-15.56
Ch3y
2.7
Ch5y
100
Ch6m
-13.64
Change
1.33%
Change From Open
1.33
Close
0.08
Days Gap
0
Depreciation Amortization
117,548
Dollar Volume
63,798.2
Earnings Date
2026-04-17
EBIT
AUD -8.5M
EBITDA
AUD -8.4M
EPS
AUD -0.01
F Score
2
FCF
AUD -6.9M
FCF EV Yield
-9.55x
FCF Per Share
AUD -0.01
Financing CF
14,592,661
Fiscal Year End
June
Founded
1,999
Investing CF
-122,363
Is Primary Listing
1
Last Earnings Date
2026-02-25
Last Report Date
2025-12-31
Last Split Date
2019-11-14
Last Split Type
Reverse
Ma150
0.08
Ma150ch
-9.52%
Ma20
0.08
Ma20ch
-3.31%
Net CF
7,615,551
Open
0.08
Position In Range
33.33
Ppne
408,733
Price Date
2026-05-08
Ptbv Ratio
4.86
Relative Volume
0.61x
Revenue
3,209,718x
SBC By Revenue
26.32x
Share Based Comp
844,923
Tr20y
-97.01%
Tr6m
-13.64%
Volume
839,450
Z Score
44.5
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/ALA pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/ALA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-10.6%
S&P 500 1Y: n/a
3Y total return
+2.7%
S&P 500 3Y: n/a
5Y total return
+100.0%
S&P 500 5Y: n/a
10Y total return
-84.2%
S&P 500 10Y: n/a
Ownership

Who owns ASX/ALA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.8%
Share of float held by funds and institutions
Insider ownership
+14.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+14.7%
Negative means the company is buying back shares.
Technical

ASX/ALA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.3
Neutral momentum band
Price vs 200-day MA
-11.6%
50/200-day relationship not available
Beta (5Y)
0.09
Less volatile than the market
Sharpe ratio
0.17
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/ALA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ALA stock rating?

asx/ALA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ALA analysis?

The full report lives at /stocks/asx/ALA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ALA?

The latest report frames asx/ALA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ALA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.